Copyright Reports & Markets. All rights reserved.

Global Sphingosine-1-Receptor Modulators Drugs Market Research Report 2021

Request for Sample of this report
Buy now

1 Sphingosine-1-Receptor Modulators Drugs Market Overview

  • 1.1 Product Overview and Scope of Sphingosine-1-Receptor Modulators Drugs
  • 1.2 Sphingosine-1-Receptor Modulators Drugs Segment by Type
    • 1.2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Fingolimod
    • 1.2.3 Siponimod
    • 1.2.4 Ozanimod
    • 1.2.5 Other
  • 1.3 Sphingosine-1-Receptor Modulators Drugs Segment by Application
    • 1.3.1 Sphingosine-1-Receptor Modulators Drugs Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Other
  • 1.4 Global Sphingosine-1-Receptor Modulators Drugs Market Size Estimates and Forecasts
    • 1.4.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue 2016-2027
    • 1.4.2 Global Sphingosine-1-Receptor Modulators Drugs Sales 2016-2027
    • 1.4.3 Sphingosine-1-Receptor Modulators Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Sphingosine-1-Receptor Modulators Drugs Market Competition by Manufacturers

  • 2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Sphingosine-1-Receptor Modulators Drugs Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Sphingosine-1-Receptor Modulators Drugs Manufacturing Sites, Area Served, Product Type
  • 2.5 Sphingosine-1-Receptor Modulators Drugs Market Competitive Situation and Trends
    • 2.5.1 Sphingosine-1-Receptor Modulators Drugs Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Sphingosine-1-Receptor Modulators Drugs Players Market Share by Revenue
    • 2.5.3 Global Sphingosine-1-Receptor Modulators Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Sphingosine-1-Receptor Modulators Drugs Retrospective Market Scenario by Region

  • 3.1 Global Sphingosine-1-Receptor Modulators Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Sphingosine-1-Receptor Modulators Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Country
    • 3.3.1 North America Sphingosine-1-Receptor Modulators Drugs Sales by Country
    • 3.3.2 North America Sphingosine-1-Receptor Modulators Drugs Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Country
    • 3.4.1 Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country
    • 3.4.2 Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Region
    • 3.5.2 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Country
    • 3.6.1 Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Country
    • 3.6.2 Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales by Country
    • 3.7.2 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Sphingosine-1-Receptor Modulators Drugs Historic Market Analysis by Type

  • 4.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2016-2021)
  • 4.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2016-2021)
  • 4.3 Global Sphingosine-1-Receptor Modulators Drugs Price by Type (2016-2021)

5 Global Sphingosine-1-Receptor Modulators Drugs Historic Market Analysis by Application

  • 5.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2016-2021)
  • 5.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2016-2021)
  • 5.3 Global Sphingosine-1-Receptor Modulators Drugs Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Novartis
    • 6.1.1 Novartis Corporation Information
    • 6.1.2 Novartis Description and Business Overview
    • 6.1.3 Novartis Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Novartis Product Portfolio
    • 6.1.5 Novartis Recent Developments/Updates
  • 6.2 Bristol-Myers Squibb
    • 6.2.1 Bristol-Myers Squibb Corporation Information
    • 6.2.2 Bristol-Myers Squibb Description and Business Overview
    • 6.2.3 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Bristol-Myers Squibb Product Portfolio
    • 6.2.5 Bristol-Myers Squibb Recent Developments/Updates
  • 6.3 Johnson & Johnson
    • 6.3.1 Johnson & Johnson Corporation Information
    • 6.3.2 Johnson & Johnson Description and Business Overview
    • 6.3.3 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Johnson & Johnson Product Portfolio
    • 6.3.5 Johnson & Johnson Recent Developments/Updates
  • 6.4 Arena Pharmaceuticals
    • 6.4.1 Arena Pharmaceuticals Corporation Information
    • 6.4.2 Arena Pharmaceuticals Description and Business Overview
    • 6.4.3 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Arena Pharmaceuticals Product Portfolio
    • 6.4.5 Arena Pharmaceuticals Recent Developments/Updates
  • 6.5 Idorsia
    • 6.5.1 Idorsia Corporation Information
    • 6.5.2 Idorsia Description and Business Overview
    • 6.5.3 Idorsia Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Idorsia Product Portfolio
    • 6.5.5 Idorsia Recent Developments/Updates
  • 6.6 Sun Pharma
    • 6.6.1 Sun Pharma Corporation Information
    • 6.6.2 Sun Pharma Description and Business Overview
    • 6.6.3 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Sun Pharma Product Portfolio
    • 6.6.5 Sun Pharma Recent Developments/Updates
  • 6.7 Biocon
    • 6.6.1 Biocon Corporation Information
    • 6.6.2 Biocon Description and Business Overview
    • 6.6.3 Biocon Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Biocon Product Portfolio
    • 6.7.5 Biocon Recent Developments/Updates
  • 6.8 HEC Pharm Co. Limited
    • 6.8.1 HEC Pharm Co. Limited Corporation Information
    • 6.8.2 HEC Pharm Co. Limited Description and Business Overview
    • 6.8.3 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 HEC Pharm Co. Limited Product Portfolio
    • 6.8.5 HEC Pharm Co. Limited Recent Developments/Updates

7 Sphingosine-1-Receptor Modulators Drugs Manufacturing Cost Analysis

  • 7.1 Sphingosine-1-Receptor Modulators Drugs Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Sphingosine-1-Receptor Modulators Drugs
  • 7.4 Sphingosine-1-Receptor Modulators Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Sphingosine-1-Receptor Modulators Drugs Distributors List
  • 8.3 Sphingosine-1-Receptor Modulators Drugs Customers

9 Sphingosine-1-Receptor Modulators Drugs Market Dynamics

  • 9.1 Sphingosine-1-Receptor Modulators Drugs Industry Trends
  • 9.2 Sphingosine-1-Receptor Modulators Drugs Growth Drivers
  • 9.3 Sphingosine-1-Receptor Modulators Drugs Market Challenges
  • 9.4 Sphingosine-1-Receptor Modulators Drugs Market Restraints

10 Global Market Forecast

  • 10.1 Sphingosine-1-Receptor Modulators Drugs Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Sphingosine-1-Receptor Modulators Drugs by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Sphingosine-1-Receptor Modulators Drugs by Type (2022-2027)
  • 10.2 Sphingosine-1-Receptor Modulators Drugs Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Sphingosine-1-Receptor Modulators Drugs by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Sphingosine-1-Receptor Modulators Drugs by Application (2022-2027)
  • 10.3 Sphingosine-1-Receptor Modulators Drugs Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Sphingosine-1-Receptor Modulators Drugs by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Sphingosine-1-Receptor Modulators Drugs by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Fingolimod
    Siponimod
    Ozanimod
    Other

    Segment by Application
    Hospital
    Clinic
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Novartis
    Bristol-Myers Squibb
    Johnson & Johnson
    Arena Pharmaceuticals
    Idorsia
    Sun Pharma
    Biocon
    HEC Pharm Co. Limited

    Buy now